XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue and Contract Acquisition Costs
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue and Contract Acquisition Costs Revenue and Contract Acquisition Costs
The following table summarizes the Company’s disaggregated revenue:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2024202320242023
U.S. Omnipod$395.6 $320.6 $1,065.6 $856.4 
International Omnipod138.0 101.4 381.4 303.7 
Total Omnipod products
533.6 422.0 1,447.0 1,160.1 
Drug Delivery10.3 10.7 27.1 27.2 
Total revenue$543.9 $432.7 $1,474.1 $1,187.3 
The percentages of total revenue for customers that represent 10% or more of total revenue were as follows:
Three Months Ended September 30,Nine Months Ended September 30,

2024202320242023
Distributor A30 %26 %28 %27 %
Distributor B25 %23 %27 %23 %
Distributor C
19 %21 %22 %18 %
Distributor D
*11 %**
* Represents less than 10% of revenue for the period.
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2024December 31, 2023
Accrued expenses and other current liabilities$22.8 $15.4 
Other liabilities2.0 1.9 
Total deferred revenue$24.8 $17.3 
Revenue recognized from amounts included in deferred revenue at the beginning of each respective period was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2024202320242023
Deferred revenue recognized$2.6 $3.0 $9.7 $15.2 
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2024December 31, 2023
Prepaid expenses and other current assets$19.3 $16.6 
Other assets39.3 32.0 
Total capitalized contract acquisition costs, net$58.6 $48.6 
The Company recognized $4.6 million and $4.1 million of amortization of capitalized contract acquisition costs during the three months ended September 30, 2024 and 2023, respectively, and recognized $13.2 million and $12.1 million of amortization of capitalized contract acquisition costs during the nine months ended September 30, 2024 and 2023, respectively.